Lupin Ties Up With German Drugmaker Boehringer To Develop, Market Cancer Drugs
An employee inspects a handful of cardiovascular treatment tablets inside a drug making facility. (Photographer: Martin Leissl/Bloomberg)

Lupin Ties Up With German Drugmaker Boehringer To Develop, Market Cancer Drugs

Lupin Ltd. has agreed to develop and commercialise a drug to treat gastrointestinal and lung cancers with the German pharmaceutical firm Boehringer lngelheim GmbH for which it would be paid $70 mil...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.